DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer

by | Nov 25, 2025 | Clinical Trials | 0 comments

​ Conditions: Non Small Cell Lung Cancer

Interventions: Drug: DRP-104

Sponsors: NYU Langone Health

Recruiting Conditions: Non Small Cell Lung Cancer
Interventions: Drug: DRP-104
Sponsors: NYU Langone Health
Recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *